Symbol="IPHA"
AssetType="Common Stock"
Name="Innate Pharma"
Description="Innate Pharma SA, a biotechnology company, discovers, develops and markets therapeutic antibodies for the treatment of oncological indications in France and internationally. The company is headquartered in Marseille, France."
CIK="1598599"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="117 AVENUE DE LUMINY, BP 30191, MARSEILLE, FR"
FiscalYearEnd="December"
LatestQuarter="2022-06-30"
MarketCapitalization="245848000"
EBITDA="-12020000"
PERatio="None"
PEGRatio="None"
BookValue="0.675"
DividendPerShare="0"
DividendYield="0"
EPS="-0.76"
RevenuePerShareTTM="0.724"
ProfitMargin="-1.007"
OperatingMarginTTM="-0.285"
ReturnOnAssetsTTM="-0.0432"
ReturnOnEquityTTM="-0.718"
RevenueTTM="57674000"
GrossProfitTTM="57674000"
DilutedEPSTTM="-0.76"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.061"
AnalystTargetPrice="8.27"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.097"
PriceToBookRatio="1.345"
EVToRevenue="2.026"
EVToEBITDA="-5.43"
Beta="0.256"
num_52WeekHigh="3.97"
num_52WeekLow="1.9"
num_50DayMovingAverage="3.104"
num_200DayMovingAverage="2.949"
SharesOutstanding="80498000"
DividendDate="None"
ExDividendDate="None"
symbol="IPHA"
open="2.89"
high="2.91"
low="2.86"
price="2.91"
volume="3129.00"
latest_trading_day="2023-08-16"
previous_close="2.89"
change="0.02"
change_percent="0.6920%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="39"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="61"
Volume_recent_avg="12610"
Change_recent_avg="0.01"
Delta_recent_avg="0.13"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="0.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="61"
Aroon_momentum_negative="39"
image_negative_thumbnail_id_1="142"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0034.jpeg"
image_negative_thumbnail_id_2="1092"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0125.jpeg"
image_neutral_thumbnail_id_1="545"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="988"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0150.jpeg"
image_positive_thumbnail_id_2="608"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0100.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
